Mycosis fungoides

Pier Luigi Zinzani, A. J M Ferreri, Lorenzo Cerroni

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Mycosis fungoides (MF) constitutes the most frequent cutaneous T-cell lymphoma. Sezary syndrome is considered by some authors to be an erythrodermic leukemic variant of MF, but is classified separately in the new WHO-EORT classification of cutaneous lymphomas. MF usually occurs in old adults with a 2:1 male to female ratio. Its prognosis is variable and strongly conditioned by the extent and type of skin involvement and presence of extracutaneous disease. Patients with stage IA-disease have an excellent prognosis with an overall long-term life expectancy that is similar to an age-, sex-, and race-matched control population. Almost all patients with stage IA MF will die from causes other than MF, with a median survival >33 years. Only 9% of these patients will progress to more extended disease. Patients with stage IB or IIA have a median survival greater than 11 years. These patients with T2 disease have a likelihood of disease progression of 24% and nearly 20% die of MF. Subgroups with stage IB or IIA have similar prognosis. Patients with cutaneous tumors or generalized erythroderma have a median survival of 3 and 4.5 years, respectively. The majority of these patients will die of MF. Extracutaneous dissemination is observed in less than 10% of patients with patch or plaque disease and in 30-40% of patients with tumors or generalized erythrodermatous involvement. Extracutaneous involvement is directly correlated to the extent of cutaneous disease. The most commonly involved organs are lung, spleen, liver, and gastrointestinal tract. Patients with extracutaneous disease at presentation involving either lymph nodes or viscera have a median survival of

Original languageEnglish
Pages (from-to)172-182
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume65
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Mycosis Fungoides
Survival
Skin
Sezary Syndrome
Exfoliative Dermatitis
Cutaneous T-Cell Lymphoma
Viscera
Life Expectancy
Skin Diseases
Disease Progression
Gastrointestinal Tract
Lymphoma
Neoplasms
Spleen
Lymph Nodes
Lung

Keywords

  • Mycosis fungoides
  • Sezary syndrome
  • T-cell lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Mycosis fungoides. / Zinzani, Pier Luigi; Ferreri, A. J M; Cerroni, Lorenzo.

In: Critical Reviews in Oncology/Hematology, Vol. 65, No. 2, 02.2008, p. 172-182.

Research output: Contribution to journalArticle

Zinzani, Pier Luigi ; Ferreri, A. J M ; Cerroni, Lorenzo. / Mycosis fungoides. In: Critical Reviews in Oncology/Hematology. 2008 ; Vol. 65, No. 2. pp. 172-182.
@article{c6e479d5362f44a0a436082be28b4951,
title = "Mycosis fungoides",
abstract = "Mycosis fungoides (MF) constitutes the most frequent cutaneous T-cell lymphoma. Sezary syndrome is considered by some authors to be an erythrodermic leukemic variant of MF, but is classified separately in the new WHO-EORT classification of cutaneous lymphomas. MF usually occurs in old adults with a 2:1 male to female ratio. Its prognosis is variable and strongly conditioned by the extent and type of skin involvement and presence of extracutaneous disease. Patients with stage IA-disease have an excellent prognosis with an overall long-term life expectancy that is similar to an age-, sex-, and race-matched control population. Almost all patients with stage IA MF will die from causes other than MF, with a median survival >33 years. Only 9{\%} of these patients will progress to more extended disease. Patients with stage IB or IIA have a median survival greater than 11 years. These patients with T2 disease have a likelihood of disease progression of 24{\%} and nearly 20{\%} die of MF. Subgroups with stage IB or IIA have similar prognosis. Patients with cutaneous tumors or generalized erythroderma have a median survival of 3 and 4.5 years, respectively. The majority of these patients will die of MF. Extracutaneous dissemination is observed in less than 10{\%} of patients with patch or plaque disease and in 30-40{\%} of patients with tumors or generalized erythrodermatous involvement. Extracutaneous involvement is directly correlated to the extent of cutaneous disease. The most commonly involved organs are lung, spleen, liver, and gastrointestinal tract. Patients with extracutaneous disease at presentation involving either lymph nodes or viscera have a median survival of",
keywords = "Mycosis fungoides, Sezary syndrome, T-cell lymphoma",
author = "Zinzani, {Pier Luigi} and Ferreri, {A. J M} and Lorenzo Cerroni",
year = "2008",
month = "2",
doi = "10.1016/j.critrevonc.2007.08.004",
language = "English",
volume = "65",
pages = "172--182",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Mycosis fungoides

AU - Zinzani, Pier Luigi

AU - Ferreri, A. J M

AU - Cerroni, Lorenzo

PY - 2008/2

Y1 - 2008/2

N2 - Mycosis fungoides (MF) constitutes the most frequent cutaneous T-cell lymphoma. Sezary syndrome is considered by some authors to be an erythrodermic leukemic variant of MF, but is classified separately in the new WHO-EORT classification of cutaneous lymphomas. MF usually occurs in old adults with a 2:1 male to female ratio. Its prognosis is variable and strongly conditioned by the extent and type of skin involvement and presence of extracutaneous disease. Patients with stage IA-disease have an excellent prognosis with an overall long-term life expectancy that is similar to an age-, sex-, and race-matched control population. Almost all patients with stage IA MF will die from causes other than MF, with a median survival >33 years. Only 9% of these patients will progress to more extended disease. Patients with stage IB or IIA have a median survival greater than 11 years. These patients with T2 disease have a likelihood of disease progression of 24% and nearly 20% die of MF. Subgroups with stage IB or IIA have similar prognosis. Patients with cutaneous tumors or generalized erythroderma have a median survival of 3 and 4.5 years, respectively. The majority of these patients will die of MF. Extracutaneous dissemination is observed in less than 10% of patients with patch or plaque disease and in 30-40% of patients with tumors or generalized erythrodermatous involvement. Extracutaneous involvement is directly correlated to the extent of cutaneous disease. The most commonly involved organs are lung, spleen, liver, and gastrointestinal tract. Patients with extracutaneous disease at presentation involving either lymph nodes or viscera have a median survival of

AB - Mycosis fungoides (MF) constitutes the most frequent cutaneous T-cell lymphoma. Sezary syndrome is considered by some authors to be an erythrodermic leukemic variant of MF, but is classified separately in the new WHO-EORT classification of cutaneous lymphomas. MF usually occurs in old adults with a 2:1 male to female ratio. Its prognosis is variable and strongly conditioned by the extent and type of skin involvement and presence of extracutaneous disease. Patients with stage IA-disease have an excellent prognosis with an overall long-term life expectancy that is similar to an age-, sex-, and race-matched control population. Almost all patients with stage IA MF will die from causes other than MF, with a median survival >33 years. Only 9% of these patients will progress to more extended disease. Patients with stage IB or IIA have a median survival greater than 11 years. These patients with T2 disease have a likelihood of disease progression of 24% and nearly 20% die of MF. Subgroups with stage IB or IIA have similar prognosis. Patients with cutaneous tumors or generalized erythroderma have a median survival of 3 and 4.5 years, respectively. The majority of these patients will die of MF. Extracutaneous dissemination is observed in less than 10% of patients with patch or plaque disease and in 30-40% of patients with tumors or generalized erythrodermatous involvement. Extracutaneous involvement is directly correlated to the extent of cutaneous disease. The most commonly involved organs are lung, spleen, liver, and gastrointestinal tract. Patients with extracutaneous disease at presentation involving either lymph nodes or viscera have a median survival of

KW - Mycosis fungoides

KW - Sezary syndrome

KW - T-cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=37549046840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549046840&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2007.08.004

DO - 10.1016/j.critrevonc.2007.08.004

M3 - Article

VL - 65

SP - 172

EP - 182

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 2

ER -